Get the Stockscreener App
101.99
4.67%
4.55
Billiontoone Inc stock is traded at $101.99, with a volume of 93,285.
It is up +4.67% in the last 24 hours and up +0.19% over the past month.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
See More
Previous Close:
$97.44
Open:
$96.01
24h Volume:
93,285
Relative Volume:
1.38
Market Cap:
$4.67B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.64%
1M Performance:
+0.19%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$95.10
$103.75
1-Week Range:
$91.58
$115.10
52-Week Range:
$88.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
-
Address
-
Compare BLLN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
101.99 | 4.46B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | BTIG Research | Buy |
| Dec-01-25 | Initiated | JP Morgan | Overweight |
| Dec-01-25 | Initiated | Jefferies | Hold |
| Dec-01-25 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Initiated | Stifel | Buy |
| Dec-01-25 | Initiated | Wells Fargo | Equal Weight |
| Dec-01-25 | Initiated | William Blair | Outperform |
View All
Billiontoone Inc Stock (BLLN) Latest News
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne price target lowered to $145 from $150 at JPMorgan - TipRanks
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks
BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com India
BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView — Track All Markets
BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks
(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com
(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com
BillionToOne Reports Third Quarter 2025 Results - The Manila Times
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - PR Newswire
Is BillionToOne’s Triple Digit Share Price Justified After Recent Volatility and Growth Hopes? - Yahoo Finance
Reassessing BillionToOne (BLLN) Valuation After a Recent Share Price Rebound - Yahoo Finance
BillionToOne initiated with an Overweight at JPMorgan - MSN
BillionToOne2025 Funding Rounds & List of Investors - Tracxn
BillionToOne, Inc.: Target Price Consensus and Analysts Recommendations | BLLN | US0901681058 - marketscreener.com
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - MSN
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne initiated with a Hold at Jefferies - MSN
BillionToOne initiated with an Overweight at Piper Sandler - MSN
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com Australia
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne initiated with an Equal Weight at Wells Fargo - MSN
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates BillionToOne at Hold With $117 Price Target - marketscreener.com
Billiontoone Inc Stock (BLLN) Financials Data
There is no financial data for Billiontoone Inc (BLLN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):